JGUA
John G. Ullman & Associates’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Sell |
1,700
-100
| -6% | -$12.7K | 0.03% | 162 |
|
|
2025
Q1 | $230K | Buy |
+1,800
| New | +$230K | 0.04% | 162 |
|
|
2024
Q4 | – | Sell |
-1,500
| Closed | -$218K | – | 180 |
|
|
2024
Q3 | $218K | Sell |
1,500
-100
| -6% | -$14.6K | 0.03% | 174 |
|
|
2024
Q2 | $220K | Sell |
1,600
-100
| -6% | -$13.7K | 0.03% | 168 |
|
|
2024
Q1 | $233K | Hold |
1,700
| – | – | 0.04% | 160 |
|
|
2023
Q4 | $231K | Sell |
1,700
-1,050
| -38% | -$143K | 0.04% | 153 |
|
|
2023
Q3 | $336K | Sell |
2,750
-50
| -2% | -$6.11K | 0.06% | 141 |
|
|
2023
Q2 | $355K | Hold |
2,800
| – | – | 0.05% | 142 |
|
|
2023
Q1 | $362K | Hold |
2,800
| – | – | 0.06% | 144 |
|
|
2022
Q4 | $368K | Buy |
+2,800
| New | +$368K | 0.06% | 137 |
|
|
2022
Q2 | – | Sell |
-1,700
| Closed | -$222K | – | 165 |
|
|
2022
Q1 | $222K | Hold |
1,700
| – | – | 0.03% | 161 |
|
|
2021
Q4 | $259K | Sell |
1,700
-300
| -15% | -$45.7K | 0.04% | 150 |
|
|
2021
Q3 | $323K | Sell |
2,000
-100
| -5% | -$16.2K | 0.04% | 137 |
|
|
2021
Q2 | $344K | Hold |
2,100
| – | – | 0.04% | 132 |
|
|
2021
Q1 | $316K | Sell |
2,100
-1,000
| -32% | -$150K | 0.04% | 131 |
|
|
2020
Q4 | $470K | Hold |
3,100
| – | – | 0.07% | 107 |
|
|
2020
Q3 | $420K | Hold |
3,100
| – | – | 0.09% | 88 |
|
|
2020
Q2 | $424K | Hold |
3,100
| – | – | 0.1% | 76 |
|
|
2020
Q1 | $334K | Hold |
3,100
| – | – | 0.09% | 84 |
|
|
2019
Q4 | $374K | Buy |
3,100
+200
| +7% | +$24.1K | 0.06% | 117 |
|
|
2019
Q3 | $289K | Buy |
+2,900
| New | +$289K | 0.05% | 120 |
|